1002 Intratumor heterogeneity in MHC-I expression drives immunotherapy resistance and exposes NKG2A as a therapeutic target in breast cancer

• Violeta Sánchez,
• Justin M Balko,
• Elizabeth Wescott,
• Melinda Sanders,
• Xiaopeng Sun,
• Susan Opalenik,
• Brandie C Taylor,
• Paula Gonzalez Ericsson,
• Ann Hanna,
• Brian Lehmann,
• Vandana Abramson,
• Jennifer Pietenpol

Affiliations

Violeta Sánchez

Vanderbilt University, Nashville, TN, United States

Justin M Balko

11 Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA

Elizabeth Wescott

Vanderbilt University, Nashville, TN, United States

Melinda Sanders

Vanderbilt University, Nashville, TN, United States

Xiaopeng Sun

Vanderbilt University Medical Center, Nashville, TN, United States

Susan Opalenik

1Vanderbilt University, Nashville, TN, United States

Brandie C Taylor

1Vanderbilt University, Nashville, TN, USA

Paula Gonzalez Ericsson

2Vanderbilt University Medical Center, Nashville, TN, USA

Ann Hanna

2Vanderbilt University Medical Center, Nashville, TN, USA

Brian Lehmann

2Vanderbilt University Medical Center, Nashville, TN, USA

Vandana Abramson

3Vanderbilt University School of Medicine, Nashville, TN, USA

Jennifer Pietenpol

3Vanderbilt University School of Medicine, Nashville, TN, USA